Home > Drug Search >
  • company_query: Attenuon
  •   > 
Drug Filter
Category:
chemistry (45) biology (2)
Status:
Approved (1) NDA Filing (1) Phase Ⅲ (9) Phase Ⅱ (18) Phase Ⅰ (17) IND Filing (1)
Clinical Stage:
Pending (10) Active (23) Discontinued (13)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Arrhythmia (1) Chronic lymphocytic leukemia (CLL) (1) Duchenne muscular dystrophy (DMD) (3) Dyslipidemia (1) Follicular lymphoma (1) HIV infection (1) Hypercholesterolemia (2) Hyperlipidemia (1) Inflammatory bowel disease (1) Leukemia (1) Lung cancer (1) Lymphoma (2) Malignancies (1) Melanoma (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (2) Overactive bladder (OAB) (1) Pancreatic cancer (2) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (1) Small cell lung cancer (SCLC) (1) Social withdrawal (1) Solid tumours (4) Marburg virus disease (2) Tuberculosis (1) Type 2 diabetes (6) Veno-occlusive disorders (1) Influenza A virus infections (1) Colorectal cancer (2) Fungal infection (1) Systemic bacterial infections (1) Malignant glioma (1) Sickle cell disease (1) Acute ischemic stroke (AIS) (1) Acute radiation syndrome (1) Astrocytoma (1) Metastatic cancer (1) West nile virus infection (1) Chronic myelomonocytic leukemia(CMML) (1) Vasomotor symptoms (1) Pharmaceutical aids (1) Coronary restenosis (1) hematological malignancies (1) Ebola virus disease (EVD) (2) Skin disorders (1)
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top